Company / Current Assets
Cocrystal Pharma, Inc. Current Assets History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$59.3M
FY2021
5-year range
$6.7M / $59.3M
FY2017-FY2021
Trend
+74.4%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has increased for 3 consecutive years, from $7M in FY2012 to $59M in FY2021.
Based on SEC 10-K filings.
$59M in FY2021.
Improved from $8M to $59M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Cocrystal Pharma, Inc.'s current assets has grown for 3 consecutive years.
- In FY2021, current assets increased 74.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $59.3M | +74.4% |
| FY2020 | $34.0M | +310.8% |
| FY2019 | $8.3M | +23.8% |
| FY2012 | $6.7M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026